Clinical Trial Update: A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure [Phase 3]

View source ↗

Summary

A Phase 3 trial of TAK-536 in children aged 2 to under 6 with hypertension has completed, and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• TAK-536

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2024-12-09